Cancer treatment and research communications · 2025
Accuracy of Image-guided Tru-cut biopsy in the diagnosis of breast tumors.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Al Zobair Alya A, Al-Nauimy Wahda M, Mohammed Sabruldeen M
Аннотация
BACKGROUND: Histopathological examination is the gold standard for the diagnosis of breast cancer. This study aims to ascertain the extent to which image-guided Tru-cut biopsy is sensitive and accurate in the diagnosis of breast cancer cases in our locality.
METHOD: This prospective study included 115 patients who presented with one or more breast lumps and suspected to be neoplastic based on the clinical and radiological assessment. All patients have been subjected to Tru-cut biopsy under ultrasound guidance to confirm or exclude the diagnosis of breast tumor, the study was conducted between January 2022 and January 2024 RESULT: Tru-cut biopsy under ultrasound-guidance has shown a high sensitivity and specificity, 98 % and 100 % respectively. Breast carcinoma was confirmed in 106 cases, while benign breast lesions were diagnosed in the remaining nine cases.
CONCLUSION: A Tru-cut biopsy of palpable breast tumors yields comprehensive information with a high sensitivity and specificity, making it a highly reliable diagnostic tool for breast tumors.
METHOD: This prospective study included 115 patients who presented with one or more breast lumps and suspected to be neoplastic based on the clinical and radiological assessment. All patients have been subjected to Tru-cut biopsy under ultrasound guidance to confirm or exclude the diagnosis of breast tumor, the study was conducted between January 2022 and January 2024 RESULT: Tru-cut biopsy under ultrasound-guidance has shown a high sensitivity and specificity, 98 % and 100 % respectively. Breast carcinoma was confirmed in 106 cases, while benign breast lesions were diagnosed in the remaining nine cases.
CONCLUSION: A Tru-cut biopsy of palpable breast tumors yields comprehensive information with a high sensitivity and specificity, making it a highly reliable diagnostic tool for breast tumors.